Coronary artery disease
Conditions
Interventions
Control Group:Non-NCT
Experimental group:NCT
Sponsors
Department of Cardiovascular Medicine, Shanghai Zhongshan Hospital affiliated to Fudan University
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Aged 18-85 years old, Male and Female; (2) Those are the first time to receive PCI operation through TRA; (3) Aspirin or other antiplatelet drugs were taken routinely before operation; (4) Adequate anticoagulation during operation, heparin dosage>=5000U(or 75U/kg); (5) Those combined with CKD, eGFR <= 60ml/min/1.73m2 over 3 months; (6) Participants have the ability to understand the research procedures, to sign the informed consent voluntarily after explanation.
Exclusion criteria
Exclusion criteria: (1) Those do not meet the coronary angiography and interventional treatment indications; (2) Those with AKI; (3) Those with pregnancy; (4) Those with severe anemia, time of malignant tumour progression,dyscrasia; (5) Those with severe hepatic insufficiency, coagulation disorders; (6) Those with infectious diseases; (7) Those with dermatosis or skin infection in the radial access for percutaneous coronary intervention; (8) Those with ipsilateral radial access history for percutaneous coronary intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RAO event happened 24 hours and 1 week after PCI; | — |
Secondary
| Measure | Time frame |
|---|---|
| subjective scoring about comfort 24 hours after PCI; | — |
Countries
China
Contacts
Public ContactZhao Gang
Shanghai Zhongshan Hospital affiliated to Fudan University
Outcome results
None listed